Mason Sam E, Scott Alasdair J, Mayer Erik, Purkayastha Sanjay
Academic Surgical Unit, Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
Academic Surgical Unit, Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK.
Am J Surg. 2016 Jun;211(6):1126-34. doi: 10.1016/j.amjsurg.2015.04.021. Epub 2015 Jul 17.
Postoperative urinary retention (POUR) is a source of avoidable patient harm. The aim of this review is to identify and quantify the role of patient-related risk factors in the development of POUR following ambulatory general surgery.
Studies published until December 2014 were identified by searching MEDLINE, EMBASE, and PsycINFO databases. Risk factors assessed in 3 or more studies were meta-analyzed.
Twenty-one studies were suitable for inclusion consisting of 7,802 patients. The incidence of POUR was 14%. Increased age and the presence of lower urinary tract symptoms significantly increased risk with odds ratios [ORs] of 2.11 (95% confidence interval [CI] 1.15 to 3.86) and 2.83 (1.57 to 5.08), respectively. Male sex was not associated with developing POUR (OR .96, 95% CI .62 to 1.50). Preoperative α-blocker use significantly decreased the incidence of POUR with an OR of .37 (95% CI .15 to .91).
Increased age and the presence of lower urinary tract symptoms increase the risk of POUR, while α-blocker use confers protection. Male sex was not associated with POUR. These findings assist in preoperative identification of patients at high risk of POUR.
术后尿潴留(POUR)是可避免的患者伤害来源。本综述的目的是确定并量化门诊普通外科手术后患者相关危险因素在POUR发生中的作用。
通过检索MEDLINE、EMBASE和PsycINFO数据库确定截至2014年12月发表的研究。对在三项或更多研究中评估的危险因素进行荟萃分析。
21项研究适合纳入,共7802例患者。POUR的发生率为14%。年龄增加和存在下尿路症状显著增加风险,优势比(OR)分别为2.11(95%置信区间[CI]1.15至3.86)和2.83(1.57至5.08)。男性与发生POUR无关(OR 0.96,95%CI 0.62至1.50)。术前使用α受体阻滞剂显著降低POUR的发生率,OR为0.37(95%CI 0.15至0.91)。
年龄增加和存在下尿路症状会增加POUR的风险,而使用α受体阻滞剂具有保护作用。男性与POUR无关。这些发现有助于术前识别POUR高危患者。